foxo4-dri senolytic human trial

foxo4-dri senolytic human trial GET RID OF ZOMBIE CELLS WITH FOXO4-DRI is like a tiny tool scientists made to get rid of old, worn-out cells in your body called senescent cells. These cells stop growing Targeted Apoptosis of Senescent Cells

Name: foxo4-dri senolytic human trial GET RID OF ZOMBIE CELLS WITH FOXO4-DRI is like a tiny tool scientists made to get rid of old, worn-out cells in your body called senescent cells. These cells stop growing Targeted Apoptosis of Senescent Cells
Brand: tmdnewgeneration.cz
SKU: 65338314044
Price: 20.84 USD
Availability: InStock
Rating: 4.5778 (7 reviews)

Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness FOXO4 DRI 10mg vial Description RCpeptides

SKU: 65338314044 · From tmdnewgeneration.cz

4.6

USD20.84 USD59.84

Pay in 4 interest-free payments of $5.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

No refrigerated vials clinking around in your travel bag

Direct human oral dose-finding trials are limited

One compound of research interest is the human peptide GHK (glycyl-L-histidyl-L-lysine), a copper-binding peptide known for its diverse biological actions that have been studied in the context of aging-related diseases and conditions

Mammalian polycomb-like Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate polycomb activity both at the Hox gene cluster and at Cdkn2a genes